Akebia Therapeutics' Grant

Akebia Therapeutics raised a round of funding on June 05, 2009. Investors include Global Cardiovascular Innovation Center.

Akebia Therapeutics is focused on delivering innovative therapies to patients with kidney disease through hypoxia-inducible factor (HIF) biology. Akebia's lead product candidate, vadadustat, is an inv…

Articles about Akebia Therapeutics' Grant: